Log in to save to my catalogue

Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients

Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_387564bac3764b149c669e768f30d439

Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients

About this item

Full title

Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients

Publisher

Switzerland: MDPI

Journal title

Diagnostics (Basel), 2021-03, Vol.11 (3), p.491

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI

Subjects

More information

Scope and Contents

Contents

Vulvar cancer incidence numbers have been rising steadily over the past decades. Especially the number of young patients with vulvar cancer increased recently. Therefore, the need to identify new prognostic factors for vulvar carcinoma is more apparent. Cyclooxygenase-2 (COX-2) has long been an object of scientific interest in the context of carcin...

Alternative Titles

Full title

Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_387564bac3764b149c669e768f30d439

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_387564bac3764b149c669e768f30d439

Other Identifiers

ISSN

2075-4418

E-ISSN

2075-4418

DOI

10.3390/diagnostics11030491

How to access this item